Geert Vergote

Deze informatie is gebaseerd op de Lirias data. Voor meer informatie ga naar lirias (opens in a new window)

01/06/2003 Risha, PG; Vervaet, C; Vergote, G; Van Bortel, L; Remon, JP
Drug formulations intended for the global market should be tested for stability under tropical climatic conditions (opens in a new window)

European Journal Of Clinical Pharmacology; 2003; Vol. 59; iss. 2; pp. 135 - 141
01/11/2002 Vergote, GJ; Kiekens, F; Vervaet, C; Remon, JP
Wax beads as cushioning agents during the compression of coated diltiazem pellets (opens in a new window)

European Journal Of Pharmaceutical Sciences; 2002; Vol. 17; iss. 3; pp. 145 - 151
01/03/2004 Vergote, GJ; De Beer, TRM; Vervaet, C; Remon, JP; Baeyens, WRG; Diericx, N; Verpoort, F
In-line monitoring of a pharmaceutical blending process using FT-Raman spectroscopy (opens in a new window)

European Journal Of Pharmaceutical Sciences; 2004; Vol. 21; iss. 4; pp. 479 - 485
01/08/2002 Risha, PG; Shewiyo, D; Msami, A; Masuki, G; Vergote, G; Vervaet, C; Remon, JP
< /i>In vitro< //i> evaluation of the quality of essential drugs on the Tanzanian market (opens in a new window)

Tropical Medicine & International Health; 2002; Vol. 7; iss. 8; pp. 701 - 707
20/06/2002 Vergote, GJ; Vervaet, C; Van Driessche, I; Hoste, S; De Smedt, S; Demeester, J; Jain, RA; Ruddy, S; Remon, JP
In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen (opens in a new window)

International Journal Of Pharmaceutics; 2002; Vol. 240; iss. 1-2; pp. 79 - 84
01/01/1991 VERGOTE, G; HEYNDRICKX, B; PAREDES, M; DAELS, J
FORENSIC DETERMINATION OF PREGNANCY HORMONES IN HUMAN BLOODSTAINS (opens in a new window)

Journal - Forensic Science Society; 1991; Vol. 31; iss. 4; pp. 409 - 419
01/07/2002 Vergote, GJ; Vervaet, C; Remon, JP; Haemers, T; Verpoort, F
Near-infrared FT-Raman spectroscopy as a rapid analytical tool for the determination of diltiazem hydrochloride in tablets (opens in a new window)

European Journal Of Pharmaceutical Sciences; 2002; Vol. 16; iss. 1-2; pp. 63 - 67
01/12/2004 De Beer, TRM; Vergote, GJ; Baeyens, WRG; Remon, JP; Vervaet, C; Verpoort, F
Development and validation of a direct, non-destructive quantitative method for medroxyprogesterone acetate in a pharmaceutical suspension using FT-Raman spectroscopy (opens in a new window)

European Journal Of Pharmaceutical Sciences; 2004; Vol. 23; iss. 4-5; pp. 355 - 362
01/08/2004 Kayumba, PC; Risha, PG; Shewiyo, D; Msami, A; Masuki, G; Ameye, D; Vergote, G; Ntawukuliryayo, JD; Remon, JP; Vervaet, C
The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania:: influence of tropical storage conditions on < /i>in vitro< //i> dissolution (opens in a new window)

Journal Of Clinical Pharmacy And Therapeutics; 2004; Vol. 29; iss. 4; pp. 331 - 338
01/12/2002 Vankeirsbilck, T; Vercauteren, A; Baeyens, W; Van der Weken, G; Verpoort, F; Vergote, G; Remon, JP
Applications of Raman spectroscopy in pharmaceutical analysis (opens in a new window)

Trac-Trends In Analytical Chemistry; 2002; Vol. 21; iss. 12; pp. 869 - 877
21/05/2001 Vergote, GJ; Vervaet, C; Van Driessche, I; Hoste, S; De Smedt, S; Demeester, J; Jain, RA; Ruddy, S; Remon, JP
An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen (opens in a new window)

International Journal Of Pharmaceutics; 2001; Vol. 219; iss. 1-2; pp. 81 - 87

Geert Vergote

Hoofdwerkplek

Contactgegevens

Werkplekken

Rollen & functies

Geert Vergote

Profiel

Hoofdwerkplek

Contactgegevens

Werkplekken

Rollen & functies

Publicaties

Publications - results